Rachel B Fissell, Marcus G Wild, David Schlundt, Devika Nair, Ebele M Umeukeje, Claudia Mueller, Andrew Guide, Robert Greevy, Kerri L Cavanaugh
{"title":"成年腹膜透析 (PD) 患者的健康心态和一年的疗效。","authors":"Rachel B Fissell, Marcus G Wild, David Schlundt, Devika Nair, Ebele M Umeukeje, Claudia Mueller, Andrew Guide, Robert Greevy, Kerri L Cavanaugh","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Many patients who start peritoneal dialysis (PD) transition to hemodialysis (HD) after a PD-related complication. Patient psychological factors may influence clinical outcomes. One possible factor is health mindset, or patient belief that their health knowledge and ability can change. The goal of this study is to evaluate the longitudinal associations of baseline health mindset with patient outcomes after one year.</p><p><strong>Methods: </strong>The Health Mindset Scale (HMS, score 3-18) was administered on paper during clinic to a convenience sample of 100 adult PD patients, to quantify patient mindset along a continuum from fixed mindset (lower scores) to growth mindset (higher scores). Participants were 31% African American, 4% Hispanic, and 64% White American. Demographic and comorbid information were abstracted from medical records. Outcomes assessed at 1 year were death, transition to HD, renal transplant, and maintaining PD.</p><p><strong>Results: </strong>HMS scores were highest in patients who subsequently received a renal transplant (mean 15, SD 2.1), indicating a growth mindset. HMS scores in patients who died were lower (mean 10, SD 5.2) suggesting a more fixed mindset. Among those who maintained PD, HMS scores were between fixed and growth mindset (mean 12.8, SD 4.2) and similar to those who transitioned to HD (mean 13, SD 4.2). One-way ANOVA for difference in HMS scores by clinical outcome was p = 0.042.</p><p><strong>Conclusions: </strong>This initial longitudinal study suggests associations between mindset and clinical outcomes. The HMS is a novel and easily administered instrument that quantifies one patient psychological component that could contribute to patient outcomes, and that could also be modified. The HMS may identify individuals who could benefit from specific interventions to favor a growth mindset, with the goal of supporting optimal clinical outcomes.</p>","PeriodicalId":520262,"journal":{"name":"SM journal of nephrology and kidney diseases","volume":"5 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11500626/pdf/","citationCount":"0","resultStr":"{\"title\":\"Health Mindset and One Year Outcomes in Adult Peritoneal Dialysis (PD) Patients.\",\"authors\":\"Rachel B Fissell, Marcus G Wild, David Schlundt, Devika Nair, Ebele M Umeukeje, Claudia Mueller, Andrew Guide, Robert Greevy, Kerri L Cavanaugh\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Many patients who start peritoneal dialysis (PD) transition to hemodialysis (HD) after a PD-related complication. Patient psychological factors may influence clinical outcomes. One possible factor is health mindset, or patient belief that their health knowledge and ability can change. The goal of this study is to evaluate the longitudinal associations of baseline health mindset with patient outcomes after one year.</p><p><strong>Methods: </strong>The Health Mindset Scale (HMS, score 3-18) was administered on paper during clinic to a convenience sample of 100 adult PD patients, to quantify patient mindset along a continuum from fixed mindset (lower scores) to growth mindset (higher scores). Participants were 31% African American, 4% Hispanic, and 64% White American. Demographic and comorbid information were abstracted from medical records. Outcomes assessed at 1 year were death, transition to HD, renal transplant, and maintaining PD.</p><p><strong>Results: </strong>HMS scores were highest in patients who subsequently received a renal transplant (mean 15, SD 2.1), indicating a growth mindset. HMS scores in patients who died were lower (mean 10, SD 5.2) suggesting a more fixed mindset. Among those who maintained PD, HMS scores were between fixed and growth mindset (mean 12.8, SD 4.2) and similar to those who transitioned to HD (mean 13, SD 4.2). One-way ANOVA for difference in HMS scores by clinical outcome was p = 0.042.</p><p><strong>Conclusions: </strong>This initial longitudinal study suggests associations between mindset and clinical outcomes. The HMS is a novel and easily administered instrument that quantifies one patient psychological component that could contribute to patient outcomes, and that could also be modified. The HMS may identify individuals who could benefit from specific interventions to favor a growth mindset, with the goal of supporting optimal clinical outcomes.</p>\",\"PeriodicalId\":520262,\"journal\":{\"name\":\"SM journal of nephrology and kidney diseases\",\"volume\":\"5 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11500626/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"SM journal of nephrology and kidney diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/8/21 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"SM journal of nephrology and kidney diseases","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/21 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:许多开始腹膜透析(PD)的患者在出现腹膜透析相关并发症后转为血液透析(HD)。患者的心理因素可能会影响临床结果。其中一个可能的因素是健康心态,即患者相信自己的健康知识和能力可以改变。本研究的目的是评估基线健康心态与患者一年后预后的纵向联系:健康心态量表(HMS,3-18 分)是在门诊期间对 100 名成年帕金森病患者进行的纸质问卷调查,以量化患者从固定心态(较低分数)到成长心态(较高分数)的连续心态。参与者中 31% 为非洲裔美国人,4% 为西班牙裔美国人,64% 为美国白人。人口统计学和合并症信息均来自医疗记录。1 年后的评估结果包括死亡、转为 HD、肾移植和维持 PD:在随后接受肾移植的患者中,HMS得分最高(平均15分,标准差2.1分),这表明患者具有成长心态。死亡患者的 HMS 得分较低(平均 10 分,标准差 5.2 分),这表明他们的思维模式较为固定。在维持腹膜透析的患者中,HMS得分介于固定型和成长型思维模式之间(平均12.8分,标准差4.2分),与过渡到血液透析的患者相似(平均13分,标准差4.2分)。临床结果对 HMS 分数差异的单因子方差分析结果为 p = 0.042:这项初步纵向研究表明,心态与临床结果之间存在关联。HMS 是一种新颖且易于管理的工具,它可以量化一个可能会影响患者预后的患者心理因素,而且还可以对其进行修改。HMS 可以确定哪些人可以从有利于成长心态的特定干预中获益,从而达到支持最佳临床结果的目的。
Health Mindset and One Year Outcomes in Adult Peritoneal Dialysis (PD) Patients.
Background: Many patients who start peritoneal dialysis (PD) transition to hemodialysis (HD) after a PD-related complication. Patient psychological factors may influence clinical outcomes. One possible factor is health mindset, or patient belief that their health knowledge and ability can change. The goal of this study is to evaluate the longitudinal associations of baseline health mindset with patient outcomes after one year.
Methods: The Health Mindset Scale (HMS, score 3-18) was administered on paper during clinic to a convenience sample of 100 adult PD patients, to quantify patient mindset along a continuum from fixed mindset (lower scores) to growth mindset (higher scores). Participants were 31% African American, 4% Hispanic, and 64% White American. Demographic and comorbid information were abstracted from medical records. Outcomes assessed at 1 year were death, transition to HD, renal transplant, and maintaining PD.
Results: HMS scores were highest in patients who subsequently received a renal transplant (mean 15, SD 2.1), indicating a growth mindset. HMS scores in patients who died were lower (mean 10, SD 5.2) suggesting a more fixed mindset. Among those who maintained PD, HMS scores were between fixed and growth mindset (mean 12.8, SD 4.2) and similar to those who transitioned to HD (mean 13, SD 4.2). One-way ANOVA for difference in HMS scores by clinical outcome was p = 0.042.
Conclusions: This initial longitudinal study suggests associations between mindset and clinical outcomes. The HMS is a novel and easily administered instrument that quantifies one patient psychological component that could contribute to patient outcomes, and that could also be modified. The HMS may identify individuals who could benefit from specific interventions to favor a growth mindset, with the goal of supporting optimal clinical outcomes.